BRPI0822143A2 - derivados de dicicloaza-alcano, processos de preparação e usos médicos dos mesmos - Google Patents

derivados de dicicloaza-alcano, processos de preparação e usos médicos dos mesmos

Info

Publication number
BRPI0822143A2
BRPI0822143A2 BRPI0822143A BRPI0822143A BRPI0822143A2 BR PI0822143 A2 BRPI0822143 A2 BR PI0822143A2 BR PI0822143 A BRPI0822143 A BR PI0822143A BR PI0822143 A BRPI0822143 A BR PI0822143A BR PI0822143 A2 BRPI0822143 A2 BR PI0822143A2
Authority
BR
Brazil
Prior art keywords
dicycloaza
preparation processes
medical uses
alkane derivatives
alkane
Prior art date
Application number
BRPI0822143A
Other languages
English (en)
Inventor
Guan Dongliang
Yang Fanglong
Zhao Fuqiang
Shen Guangyuan
Lü Hejun
Fu Jianhong
Li Li
Wang Lin
Cho Tang Peng
Lin Zhigang
Original Assignee
Jiangsu Hansoh Pharmaceutical Cio Ltd
Shangai Hengrui Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CN 200810004727 external-priority patent/CN101230059B/zh
Application filed by Jiangsu Hansoh Pharmaceutical Cio Ltd, Shangai Hengrui Pharmaceutical Co Ltd filed Critical Jiangsu Hansoh Pharmaceutical Cio Ltd
Publication of BRPI0822143A2 publication Critical patent/BRPI0822143A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
BRPI0822143A 2008-01-23 2008-05-20 derivados de dicicloaza-alcano, processos de preparação e usos médicos dos mesmos BRPI0822143A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN 200810004727 CN101230059B (zh) 2007-01-23 2008-01-23 双环氮杂烷类衍生物、其制备方法及其在医药上的用途
PCT/CN2008/071014 WO2009094866A1 (fr) 2008-01-23 2008-05-20 Dérivés de dicycloazaalcane, leurs procédés de préparation et utilisations médicales

Publications (1)

Publication Number Publication Date
BRPI0822143A2 true BRPI0822143A2 (pt) 2019-09-24

Family

ID=40921930

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0822143A BRPI0822143A2 (pt) 2008-01-23 2008-05-20 derivados de dicicloaza-alcano, processos de preparação e usos médicos dos mesmos

Country Status (9)

Country Link
US (2) US8304411B2 (pt)
EP (1) EP2246347B1 (pt)
JP (1) JP5438028B2 (pt)
KR (1) KR101469306B1 (pt)
BR (1) BRPI0822143A2 (pt)
CA (1) CA2712352C (pt)
MX (1) MX2010008049A (pt)
RU (1) RU2487866C2 (pt)
WO (1) WO2009094866A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102174007B (zh) * 2011-03-11 2013-06-12 成都博天化工有限责任公司 [2-(2-氰基-吡咯烷-1-基)-2-氧代-乙基]-氨基甲酸叔丁基酯的工业化制备方法
US9527851B2 (en) 2011-12-21 2016-12-27 Jiangsu Hengrui Medicine Co., Ltd. Pyrrole six-membered heteroaryl ring derivative, preparation method thereof, and medicinal uses thereof
CN103508931B (zh) 2012-06-25 2016-03-02 广东东阳光药业有限公司 六氢并环戊二烯衍生物、其制备方法及其在医药上的应用
CN104030967B (zh) * 2013-03-05 2018-01-02 连云港恒运药业有限公司 一种dpp‑iv抑制剂的中间体、其制备方法和通过其制备dpp‑iv抑制剂的方法
WO2015048507A1 (en) 2013-09-26 2015-04-02 Mnemosyne Pharmaceuticals, Inc. Selective octahydro-cyclopenta[c] pyrrole negative modulators of nr2b
JO3579B1 (ar) * 2014-09-26 2020-07-05 Luc Therapeutics Inc مُعدِلات تفاغرية سالبة لمستقبل nr2b من المركب n-ألكيل أريل-5-أوكسي أريل-ثامن هيدرو-خماسي الحلقة [c] بيرول
US20170301620A1 (en) * 2016-04-15 2017-10-19 International Business Machines Corporation Structure and process for metal cap integration

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5280028A (en) * 1992-06-24 1994-01-18 G. D. Searle & Co. Benzimidazole compounds
KR970703324A (ko) 1994-05-18 1997-07-03 쇼오다 오사무 신규한 피리미딘 유도체(novel pyrimidine derivative)
TW492957B (en) 1996-11-07 2002-07-01 Novartis Ag N-substituted 2-cyanopyrrolidnes
US6110949A (en) 1999-06-24 2000-08-29 Novartis Ag N-(substituted glycyl)-4-cyanothiazolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
EP1399433B1 (en) 2001-06-27 2007-08-22 Smithkline Beecham Corporation Fluoropyrrolidines as dipeptidyl peptidase inhibitors
US6861440B2 (en) * 2001-10-26 2005-03-01 Hoffmann-La Roche Inc. DPP IV inhibitors
HUP0200849A2 (hu) 2002-03-06 2004-08-30 Sanofi-Synthelabo N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
TW200401635A (en) * 2002-07-23 2004-02-01 Yamanouchi Pharma Co Ltd 2-Cyano-4-fluoropyrrolidine derivative or salt thereof
EP1613315B1 (en) * 2003-04-04 2009-01-21 Novartis AG Quinoline-2-one-derivatives for the treatment of airways diseases
GB0307856D0 (en) 2003-04-04 2003-05-14 Novartis Ag Organic compounds
JP4689599B2 (ja) * 2004-02-27 2011-05-25 杏林製薬株式会社 ビシクロ誘導体
FR2870538B1 (fr) * 2004-05-19 2006-07-14 Servier Lab Nouveaux derives de pyrrolidines et de thiazolidines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP1778688A1 (en) * 2004-07-22 2007-05-02 Glaxo Group Limited Antibacterial agents
ATE507832T1 (de) 2004-09-03 2011-05-15 Athersys Inc Trizyklische heteroaryl-piperazine, pyrrolidine und azetidine als serotonin-rezeptor-modulatoren
EP1931633A2 (en) * 2005-09-05 2008-06-18 Ranbaxy Laboratories Limited Derivatives of 3-azabicyclo[3.1.0]hexane as dipeptidyl peptidase-iv inhibitors
CN101050194B (zh) 2006-04-05 2013-08-21 上海恒瑞医药有限公司 双环辛烷类衍生物、其制备方法及其在医药上的用途
CN101230058A (zh) * 2007-01-23 2008-07-30 上海恒瑞医药有限公司 双环氮杂烷类衍生物、其制备方法及其在医药上的用途
CN101230059B (zh) 2007-01-23 2011-08-17 上海恒瑞医药有限公司 双环氮杂烷类衍生物、其制备方法及其在医药上的用途

Also Published As

Publication number Publication date
MX2010008049A (es) 2010-11-12
CA2712352A1 (en) 2009-08-06
EP2246347A1 (en) 2010-11-03
EP2246347A4 (en) 2012-01-11
JP5438028B2 (ja) 2014-03-12
US8415349B2 (en) 2013-04-09
RU2010128972A (ru) 2012-02-27
KR20100103881A (ko) 2010-09-28
JP2011510026A (ja) 2011-03-31
AU2008349110A1 (en) 2009-08-06
US20100311747A1 (en) 2010-12-09
KR101469306B1 (ko) 2014-12-04
EP2246347B1 (en) 2016-09-28
US8304411B2 (en) 2012-11-06
CA2712352C (en) 2016-05-10
WO2009094866A1 (fr) 2009-08-06
US20130012705A1 (en) 2013-01-10
RU2487866C2 (ru) 2013-07-20

Similar Documents

Publication Publication Date Title
BRPI0920927A2 (pt) derivados de azaquinolinona e usos dos mesmos
BRPI0911004A2 (pt) Artigo antimicrobiano, líquido de tratamento e métodos de preparação dos mesmos
BR112013011968A2 (pt) composição farmacêutica, métodos de tratamento e usos da mesma
BRPI0914682A2 (pt) compostos de heteroarila e usos dos mesmos
BRPI1009324A2 (pt) compostos e/ou farmaceuticamente aceitáveis dos mesmos, composição farmacêutica e respectivos usos
BR112013015592A8 (pt) derivados de biciclo-[3.2.1]-octilamida e usos dos mesmos
BR112012006404A2 (pt) derivados de di-hidropteridinona, processo de preparação e uso farmacêutico dos mesmos
BRPI0818477A2 (pt) Dc-sign, icam-3 e lsectin porcinos e usos dos mesmos
BRPI1014997A2 (pt) compostos heteroarila e usos dos mesmos
FR2933700B1 (fr) Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
FR2945534B1 (fr) DERIVES DE CYCLOPENTAL[c]PYRROLE-2-CARBOXYLATES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
BRPI0917250A2 (pt) sistema para detecção de tecido em um paciente, sistema para detectar característica de tecido em um paciente
DK2479174T3 (da) 6-aminoquinazolin- eller 3-cyanquinolinderivater, fremstillingsfremgangsmåder og farmaceutiske anvendelser deraf
BRPI0920026A2 (pt) método de tratamento de infecção pulmonar, composição farmacêutica e respectivos usos.
BRPI1013943A2 (pt) Composto cetais e usos dos mesmos.
BRPI0908021A2 (pt) Composto, composição farmacêutica, e, usos do composto ou da composição farmacêutica
BRPI0915897A2 (pt) compostos derivados triazóis, composições farmacêuticas e combinações dos mesmos e seus usos
BRPI1009372A2 (pt) compostos, composição farmacêutica e respectivos usos
BRPI0822337A2 (pt) Folatos, composições e usos dos mesmos
BRPI0922691A2 (pt) conjugados de leptina e análogo de leptina e usos dos mesmos
FR2953520B1 (fr) Derives de diphenyl-pyrazolopyridines, leur preparation et leur application en therapeutique
BRPI0915680A2 (pt) miméticos de glicocorticoide, métodos de prepará-los, composições farmacêuticas, e usos dos mesmos
BRPI0715342A2 (pt) Derivados de 6-carboxi-normorfinano, síntese e usos dos mesmos
FR2915199B1 (fr) Derives de triazolopyridine-carboxamides et triazolopyrimidine-carboxamides, leur preparation et leur application en therapeutique.
FR2952934B1 (fr) Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.